Download Citation
Article Source:
The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors
Yu EJ,
Bell DW
(2024)
The endometrial cancer A230V-ALK5 (TGFBR1) mutant attenuates TGF-β signaling and exhibits reduced in vitro sensitivity to ALK5 inhibitors.
PLOS ONE 19(11): e0312806.
https://doi.org/10.1371/journal.pone.0312806